This inventor holds 1 USPTO granted patent. Top assignees: Dartmouth College, Somatogenetics International, Inc.. Active years: 1989.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 708 
1 out of 2 Years Active: 1989
Title: Thomas A. Spencer: Innovator in Cholesterol Regulation
Introduction
Thomas A. Spencer is a notable inventor based in Hanover, NH (US). He has made significant contributions to the field of pharmaceuticals, particularly in the area of cholesterol regulation. His innovative work has the potential to impact health and wellness positively.
Latest Patents
Thomas A. Spencer holds a patent for "Squalene oxide cyclase inhibitors and therapeutic use thereof." This patent focuses on Azadecalins and C-7 substituted decalins, which exhibit squalene oxide cyclase inhibitory activity. These compounds are useful as inhibitors of cholesterol synthesis and may be employed in pharmaceuticals to regulate cholesterol levels in mammals.
Career Highlights
Throughout his career, Thomas has worked with various organizations, including Somatogenetics International, Inc. and Dartmouth College. His experience in these institutions has allowed him to develop and refine his innovative ideas in the pharmaceutical sector.
Collaborations
One of his notable collaborators is Michael Sinensky. Their partnership has contributed to advancements in the research and development of cholesterol-regulating therapies.
Conclusion
Thomas A. Spencer's work exemplifies the intersection of innovation and health, showcasing how targeted inventions can lead to significant improvements in medical treatments. His contributions to cholesterol regulation through his patented inventions highlight the importance of research and collaboration in the field of pharmaceuticals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile